A novel class of adenosine A3 receptor ligands. 1. 3-(2- pyridinyl)isoquinoline derivatives

Journal of Medicinal Chemistry

Volumn 41, Issue 21, 1998, Pages 3987-3993

  Van Muijlwijk Koezen, Jacqueline E ^a,c   Timmerman, Henk ^a   Link, Regina ^b   Van der Goot, Henk ^a   Ijzerman, Adriaan P ^b  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

4 METHOXY N [3 (2 PYRIDINYL)ISOQUINOLIN 1 YL]BENZAMIDINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE A3 RECEPTOR; BENZAMIDINE DERIVATIVE; N [3 (2 PYRIDINYL)ISOQUINOLIN 1 YL]BENZAMIDINE; UNCLASSIFIED DRUG; VUF 8501; VUF 8505;

ARTICLE; DRUG ACTIVITY; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; NONHUMAN; RAT; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

ANIMALS; BENZAMIDINES; CELL LINE; CEREBRAL CORTEX; CHO CELLS; CORPUS STRIATUM; CRICETINAE; HUMANS; ISOQUINOLINES; LIGANDS; RATS; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A3; RECEPTORS, PURINERGIC P1; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032497633     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm980036q     Document Type: Article

References (38)

1. Olah, M. E.; Stiles, G. L. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu. Rev. Pharmacol. Toxicol. 1995, 35, 581-606.
2. Meyerhof, W.; Müller-Brechlin, R.; Richter, D. Molecular cloning of a novel putative G-protein coupled receptor expressed during rat spermiogenesis. FEBS Lett. 1991, 284, 155-160.
3. 3 adenosine receptor. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 7432-7436.
4. 3 adenosine receptor. Biochim. Biophys. Acta 1993, 1179, 105-107.
5. 3 adenosine receptor. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 10365-10369.
6. 3 receptors: Pharmacological properties, species differences and receptor functions. Trends Pharmacol. Sci. 1994, 15, 298-306.
7. 3 adenosine receptor gene, adora3. Genomics 1995, 30, 118-119.
8. 3 Receptors. J. Pharmacol. Exp. Ther. 1997, 280, 122-128.
9. 3 adenosine receptor with widespread tissue distribution. Mol. Pharmacol. 1993, 44, 524-532.
10. 3 receptor-mediated hypotension in the rat. Br. J. Pharmacol. 1995, 115, 945-952.
11. 3 receptor agonist 2-Cl-IB-MECA in conscious rats. Eur. J. Pharmacol. 1996, 308, 311-314.
12. 3 receptor. Cancer Res. 1994, 54, 3521-3526.
13. 3 receptor stimulation on seizures in mice. Eur. J. Pharmacol. 1995, 275, 23-29.
14. 3 receptor stimulation and cerebral ischemia. Eur. J. Pharmacol. 1994, 263, 59-67.
15. 3 receptor - N-6-2-(4-aminophenyl)ethyladenosine induces bronchospasm in bde rats by a neurally mediated mechanism involving cells resembling mast cells. J. Pharmacol. Exp. Ther. 1996, 279, 1148-1156.
16. 3AR is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J. Biol. Chem. 1993, 268, 16887-16890.
17. 3-adenosine receptors: design of selective ligands and therapeutic prospects. Drugs of the Future 1995, 20, 689-699.
18. 3 adenosine receptors. J. Med. Chem. 1994, 37, 3373-3382.
19. 3 receptors. J. Med. Chem. 1996, 39, 2980-2989.
20. 3 receptor subtype. J. Med. Chem. 1096, 39, 4142-4148.
21. 3 adenosine receptor antagonists. Drug Dev. Res. 1996, 37, 131.
22. Goot, H. v. d. 1-Aminoisoquinolines - Synthesis and properties; Ph.D. Thesis, Vrije Universiteit Amsterdam, 1972.
23. Gaisser, H.-D. The role of copper in the mode of action of 2,2′-bipyridyl analogues with antimycoplasmal activity - a (Q)SAR study; Ph.D. Thesis, Vrije Universiteit Amsterdam, 1985.
24. Smit, H. Studies on the mode of action of the copper(I)complex of 2,9-dimethyl-1,10-phenanthroline on paracoccus denitrificans and mycoplasma gallisepticum; Ph.D. Thesis, Vrije Universiteit Amsterdam, 1982.
25. Pijper, P. J. Synthesis and antimycoplasmal activity of compounds structurally related to 2,2′-bipyridyl; Ph.D. Thesis, Vrije Universiteit Amsterdam, 1980.
26. Zwart, M. A. H. d. Synthesis and copper-dependent antimycoplasmal activity of 3-(2-pyridyl)isoquinoline and 1,10-phenanthroline derivatives; Ph.D. Thesis, Vrije Universiteit Amsterdam, 1989.
27. Zwart, M. A. H. d.; Goot, H. v. d.; Timmerman, H. Synthesis and copper dependent antimycoplasmal activity of 1-amino-3-(2-pyridyl)isoquinoline derivatives. 1. Amides. J. Med. Chem. 1988, 31, 716-722.
28. Pijper, P. J.; Goot, H. v. d.; Timmerman, H.; Nauta, W. T. Synthesis and antimycoplasmal activity of 2,2′-bipyridyl analogues. Part II. 1-substituted-3-(2-pyridyl)isoquinolines. Eur. J. Med. Chem.-Chim. Ther. 1984, 19, 393-397.
29. Linschoten, M. R.; Gaisser, H.-D.; Goot, H. v. d.; Timmerman, H. Synthesis and copper dependent antimycoplasmal activity of quinazolinylamidines and amides: a case of concentration quenching. Eur. J. Med. Chem.-Chim. Ther. 1984, 19, 137-142.
30. Roger, R.; Neilson, D. G. The chemistry of imidates. Chem. Rev. 1961, 61, 179-211.
31. Coudert, G.; Guillaumet, G.; Lalloz, L.; Caubére, P. Synthesis of 2-(2-oxoalkyl)-quinolines and 4-(2-oxoalkyl)-quinolines. Synthesis 1976, 764-766.
32. 6-(w-aminoalkyl)-adenosines on adenosine receptor affinity and intrinsic activity. Eur. J. Pharmacol. 1989, 172, 185-191.
33. 2 receptors in rat brain. J. Pharmacol. Exp. Ther. 1989, 251, 888-893.
34. 3 adenosine receptor. Mol. Pharmacol. 1994, 45, 1101-1111.
35. 3 adenosine receptor. Mol. Pharmacol. 1994, 45, 978-982.
36. 3 receptor using the semliki forest virus expression system. Drug Dev. Res. 1997, 40, 35-40.
37. Ewing, E. W.; Steck, E. A. Absorption spectra of heterocyclic compounds. I. Quinolinols and isoquinolinols. J. Am. Chem. Soc. 1946, 68, 2181-2187.
38. Zwart, M. A. H. d.; Goot, H. v. d.; Timmerman, H. Synthesis and copper dependent antimycoplasmal activity of 1-amino-3-(2-pyridyl)isoquinoline derivatives. 2. Amidines. J. Med. Chem. 1989, 32, 487-493.